Cargando…

Clinical value of lncRNA CCAT1 in serum extracellular vesicles as a potential biomarker for gastric cancer

Long non-coding RNAs (lncRNAs) in extracellular vesicles (EVs) are considered to be novel non-invasive biomarkers for gastric cancer (GC). lncRNA colon cancer-associated transcript 1 (CCAT1) is aberrantly expressed in certain types of cancer. However, the role of EV lncRNA CCAT1 in patients with GC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Ke, Dong, Zhaogang, Wang, Ding, Liu, Min, Ding, Juan, Chen, Wendan, Shang, Ziqi, Yue, Congbo, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045156/ https://www.ncbi.nlm.nih.gov/pubmed/33868485 http://dx.doi.org/10.3892/ol.2021.12708

Ejemplares similares

Expression and clinical value of circRNAs in serum extracellular vesicles for gastric cancer
por: Xiao, Ke, et al.
Publicado: (2022)

LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion
por: Yan, Lihua, et al.
Publicado: (2018)

LncRNA CCAT1 is overexpressed in tuberculosis patients and predicts their survival
por: Ye, Taosheng, et al.
Publicado: (2021)

LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement
por: Zhang, Cong, et al.
Publicado: (2023)

LncRNA CCAT1 functions as apoptosis inhibitor in podocytes via autophagy inhibition
por: Su, Yanyan, et al.
Publicado: (2019)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
por: Zhang, Caixiang, et al.
Publicado: (2019)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424
por: Ding, Jun, et al.
Publicado: (2020)

CRISPR/Cas9 Knockout Strategies to Ablate CCAT1 lncRNA Gene in Cancer Cells
por: Zare, Khadijeh, et al.
Publicado: (2018)

Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
por: Yang, Chun, et al.
Publicado: (2019)

A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer
por: Wang, Li, et al.
Publicado: (2023)

Extracellular vesicle-mimetic nanovesicles transport LncRNA-H19 as competing endogenous RNA for the treatment of diabetic wounds
por: Tao, Shi-Cong, et al.
Publicado: (2018)

A five-lncRNA model predicting overall survival in gastric cancer compared with normal tissues
por: Cai, Congbo, et al.
Publicado: (2021)

Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets
por: Jiang, Chengyao, et al.
Publicado: (2023)

The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a
por: Lv, Li, et al.
Publicado: (2018)

Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus
por: Xiang, Jian-Feng, et al.
Publicado: (2014)

The lncRNA CCAT2 Rs6983267 G Variant Contributes to Increased Sepsis Susceptibility in a Southern Chinese Population
por: Wu, Zhiyuan, et al.
Publicado: (2021)

Polymorphisms in lncRNA CCAT1 on the susceptibility of lung cancer in a Chinese northeast population: A case–control study
por: Ji, Yangtao, et al.
Publicado: (2022)

Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer
por: Cao, Xiaoli, et al.
Publicado: (2022)

A Comprehensive Exploration of the lncRNA CCAT2: A Pan-Cancer Analysis Based on 33 Cancer Types and 13285 Cases
por: Huang, Bowen, et al.
Publicado: (2020)

lncRNA CCAT1 Acts as a MicroRNA-218 Sponge to Increase Gefitinib Resistance in NSCLC by Targeting HOXA1
por: Jin, Xiang, et al.
Publicado: (2020)

LncRNA PRNCR1 rs1456315 and CCAT2 rs6983267 Polymorphisms on 8q24 Associated with Lung Cancer
por: Yu, Wei-Ling, et al.
Publicado: (2021)

LncRNA‐encoded microproteins: A new form of cargo in cell culture‐derived and circulating extracellular vesicles
por: Cai, Tanxi, et al.
Publicado: (2021)

Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer
por: Xu, Hao, et al.
Publicado: (2020)

Small extracellular vesicles with LncRNA H19 “overload”: YAP Regulation as a Tendon Repair Therapeutic Tactic
por: Tao, Shi-Cong, et al.
Publicado: (2021)

Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics
por: Jia, Fan, et al.
Publicado: (2021)

Knockdown of lncRNA CCAT1 Inhibits the Progression of Colorectal Cancer via hsa-miR-4679 Mediating the Downregulation of GNG10
por: Wang, Ning, et al.
Publicado: (2021)

The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses
por: Yue, Congbo, et al.
Publicado: (2022)

LncRNA-Profile-Based Screening of Extracellular Vesicles Released from Brain Endothelial Cells after Oxygen–Glucose Deprivation
por: He, Xiang, et al.
Publicado: (2022)

Extracellular Vesicle-Transported Long Non-Coding RNA (LncRNA) X Inactive-Specific Transcript (XIST) in Serum is a Potential Novel Biomarker for Colorectal Cancer Diagnosis
por: Yu, Jinfeng, et al.
Publicado: (2020)

Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1
por: Li, Xiaohui, et al.
Publicado: (2020)

LncRNA CCAT1 Promotes Colorectal Cancer Tumorigenesis Via A miR-181b-5p/TUSC3 Axis
por: Chen, Si, et al.
Publicado: (2019)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer
por: Ding, Xian-zhen, et al.
Publicado: (2021)

Extracellular Matrix–Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer
por: Qing, Liangliang, et al.
Publicado: (2020)

lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line
por: Yang, Tianzheng, et al.
Publicado: (2018)

Evaluation of FOXCUT, CCAT2, and HULC LncRNA Expression Levels and Apoptosis Induction by Sodium Butyrate in PC-3 and LNCAP Prostate Cancer Cell Lines
por: Kavousi, Sanaz, et al.
Publicado: (2021)

LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation
por: Gao, Haibing, et al.
Publicado: (2022)

The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis
por: Xia, Hongwei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j20ace1qir6bom5lpl8km5odrp